Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Yoshinobu Onuma
ResearcherPublications, citations & collaboration network
Yoshinobu Onuma is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 1,173 works, 37,217 citations, an h-index of 96 and an i10-index of 515.
1,173
Works
37,217
Citations
96
h-index
515
i10-index
How has Yoshinobu Onuma's publication output changed over time?
ScholarIQpublication output · 2008–2021
Output grew100% over the shown period — from 1 works in 2008 to 2 in 2021.
1
2
1
1
1
1
2
1
2
200820092011201320142016201820202021
What are the most-cited papers on Yoshinobu Onuma?
ScholarIQmost cited works
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
Héctor M. García‐García, Eugène McFadden, Andrew Farb, Roxana Mehran, Gregg W. Stone, John A. Spertus, Yoshinobu Onuma, Marie‐Angèle Morel, Gerrit‐Anne van Es, Bram Zuckerman, William F. Fearon, David P. Taggart, A. Pieter Kappetein, Mitchell W. Krucoff, Pascal Vranckx, Stephan Windecker, Donald E. Cutlip, Patrick W. Serruys
Circulation. 2018956 CitationsOPEN ACCESS
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II
Vasim Farooq, David van Klaveren, Ewout W. Steyerberg, Emanuele Meliga, Yvonne Vergouwe, Alaide Chieffo, A. Pieter Kappetein, Antonio Colombo, David R. Holmes, Michael J. Mack, Ted Feldman, Marie-Claude Morice, Elisabeth Ståhle, Yoshinobu Onuma, Marie-angèle Morel, Héctor M. García‐García, Gerrit Anne van Es, Keith D. Dawkins, Friedrich W. Mohr, Patrick W. Serruys
The Lancet. 2013834 Citations
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
Patrick W. Serruys, John A. Ormiston, Yoshinobu Onuma, Evelyn Regar, Nieves Gonzalo, Héctor M. García‐García, Koen Nieman, Nico Bruining, Cécile Dorange, Karine Miquel‐Hébert, Susan Veldhof, Mark Webster, Leif Thuesen, Dariusz Dudek
The Lancet. 2009818 Citations
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Pascal Vranckx, Marco Valgimigli, Peter Jüni, Christian W. Hamm, Philippe Gabríel Steg, Dik Heg, Gerrit Anne van Es, Eugène McFadden, Yoshinobu Onuma, Cokky van Meijeren, Ply Chichareon, Edouard Benit, Helge Möllmann, Luc Janssens, Maurizio Ferrario, Aris Moschovitis, Aleksander Żurakowski, Marcello Dominici, Robert‐Jan van Geuns, Kurt Huber, Ton Slagboom, Patrick W. Serruys, Stephan Windecker, Mohamed Abdellaoui, David Adlam, İbrahim Akın, Agustín Albarrán González-Trevilla, Manuel Almeida, Pedro A. Lemos, Adel Aminian, Richard Anderson, Rick Andreae, Michaël Angioı̈, Taku Asano, Emanuele Barbato, Peter Barlis, Pascal Barraud, Edouard Benit, Olivier F. Bertrand, Farzin Beygui, Leonardo Bolognese, Roberto Botelho, Coby Bouwman, Marco Bressers, Philippe Brunel, Paweł Buszman, Ian Buysschaert, Pedro Canas da Silva, Didier Carrié, Ángel Cequier, Ply Chichareon, Chun Chin Chang, Saqib Chowdhary, Carlos Collet, Antonio Colombo, James Cotton, Rui Cruz Ferreira, Salvatore Curello, Nick Curzen, Judith de Bot, Tone de Vreede, Georg Delle Karth, Lynn Dijksma, Marcello Dominici, István Édes, Éric Eeckhout, Ingo Eitel, József Faluközy, Farzin Fath‐Ordoubadi, Maurizio Ferrario, Géza Fontos, José Francisco Díaz Fernández, Edgard Freitas Quintella, Bernhard Frey, Guy Friedrich, Gavin Galasko, G. Gałuszka, Vasco Gama Ribeiro, Scot Garg, Giuseppe Gargiulo, Tobias Geisler, Валери Гелев, Art Ghandilyan, Javier Goicolea, Tommaso Gori, Felice Gragnano, Ana Guimarães, Christian W. Hamm, Michael Haude, Dik Heg, Pieter Heijke, Rosa Ana Hernández Antolín, David Hildick‐Smith, Dorien Hillen, Ina Hoekman, Sjoerd H. Hofma, Lene Holmvang, Stephen P. Hoole, Iván Horváth, Kurt Huber
The Lancet. 2018793 CitationsOPEN ACCESS
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
John A. Ormiston, Patrick W. Serruys, Evelyn Regar, Dariusz Dudek, Leif Thuesen, Mark Webster, Yoshinobu Onuma, Héctor M. García‐García, Robert McGreevy, Susan Veldhof
The Lancet. 2008716 Citations
Related on ScholarIQ
Ollscoil na Gaillimhe – University of Galway
Institution
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
Paper
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II
Paper
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
Paper
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Paper
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
Paper